Company Overview and News


Add 539523
to your dashboard

Headline News

Companies fall silent post condom ad restriction

14h business-standard
Viveat Susan Pinto & T E Narasimhan  |  Mumbai/Chennai  Last Updated at December 13, 2017 02:04 IST

Shalby IPO subscribed fully; issue closes today

2017-12-07 thehindubusinessline
The initial public offer of Shalby Ltd, the Ahmedabad-based multi-specialty hospital chain, was subscribed 1.08 times in morning session on the last day of the bidding today. The IPO, which aims to raise Rs 504 crore, received bids for 1,57,11,900 shares against the total issue size of 1,45,21,686 shares - a subscription of 1.08 per cent - data available with NSE till 11.30 am showed.

Alkem Laboratories Limited - Shareholders meeting

2017-12-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Alkem Laboratories gains 1%; Credit Suisse keeps outperform rating with target of Rs 2275

2017-11-30 moneycontrol
Shares of Alkem Laboratories added nearly 1 percent as the foreign broking house Credit Suisse has maintained outperform rating on the stock.

Alkem Labs up 8% as Motilal Oswal upgrades to buy on domestic biz; USFDA nod for Capecitabine

2017-11-29 moneycontrol
Alkem Laboratories share price rallied as much as 8.5 percent in morning Wednesday after Motilal Oswal has upgraded its rating to buy from neutral on the stock, citing likely strong domestic business growth.

Market Live: Sensex higher, Nifty eyes 10,400 despite North Korea missile launch

2017-11-29 moneycontrol
9:50 am Rupee Trade: The rupee is trading flat after seeing depreciation of 10 paise to 64.51 against the US dollar in opening at the interbank foreign exchange due to appreciation of the American currency overseas. (17-0)

Alkem Labs Q2 net up 14% at Rs 327 cr on robust sales

2017-11-10 business-standard
Drug firm Alkem Laboratories on Friday reported a 13.63 per cent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30 on account of robust sales. The company had posted a net profit of Rs 288.15 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.

Alkem Laboratories Limited - Financial Result Updates

2017-11-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Alkem Laboratories Limited - Investor Presentation

2017-11-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Alkem Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2017-11-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

U.S. states allege broad generic drug price-fixing collusion

2017-11-01 in.reuters
WASHINGTON (Reuters) - A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling. (36-0)

U.S. states allege broad generic drug price-fixing collusion, triggering fall in pharmaceutical stocks

2017-11-01 japantimes.co.jp
WASHINGTON – A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drug makers and medicines in an action that sent some company shares tumbling. (36-0)

States move to expand generic drug price-fixing lawsuit

2017-10-31 channelnewsasia
Forty-six U.S. state attorneys general will seek to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG's generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd, people familiar with the matter said. (31-0)

UPDATE 2-U.S. states move to expand generic drug price-fixing lawsuit

2017-10-31 reuters
WASHINGTON (Reuters) - A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s (NOVN.S) generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd (SUN.NS). (31-0)